Reply on the Letter by Stott et al. The Dilemma of Treating Subclinical Hypothyroidism: Risk that Current Guidelines Do More Harm than Good7

摘要

We appreciate the interest of Stott et al. [1] in the Management of Subclinical Hypothyroidism ETA Guidelines 2013 [2]. We are, however, somewhat puzzled by the authors' statement that the guidelines 'risk doing more harm than good', probably the result of misinterpretation of some recommendations of the guidelines.The ETA Guidelines represent a meticulous interpretation of more than 140 articles and were, moreover, posted on the ETA website for about a month for criticism and comments. They offer a unique platform of expertise, supporting those involved in the diagnosis and treatment of both younger and older patients with subclinical hypothyroidism (SCH), in a spirit of collaboration for the benefit of our patients.